Product Images Pamidronate Disodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Pamidronate Disodium NDC 59923-602 by Areva Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

30mg Vial - 30 mg vial small

30mg Vial - 30 mg vial small

Each vial contains 30mg of Pamidronate Disodium in lyophilized form with mannitol USP 470mg and phosphoric acid to adjust pH. The pH of the reconstituted solution is 6.0-7.0. It is not recommended to mix with calcium-containing infusion solutions. Further dilution is required and the dilution and administration differs for each indication. It is for intravenous infusion and should be stored at 20° - 25°C. It is manufactured by Cipla Ltd. for AREVA Pharmaceuticals Inc. located in Georgetown, Indiana, USA.*

30mg Carton - 30mgcarton

30mg Carton - 30mgcarton

Description not available. The text appears to be fragmented and incomplete.*

60mg Vial - 60 mg label

60mg Vial - 60 mg label

Each vial of this product with NDC code 59923-602-10 contains a sterile, lyophilized powder for injection. The reconstituted solution should have a pH between 6.0 and 7.0 and should not be mixed with calcium-containing infusion solutions. Dilution and administration instructions may differ based on manufacturer. Store at controlled room temperature. This product is manufactured by Cipla Ltd in India and distributed by AREVA Pharmaceuticals, Inc. No additional information is available in the provided text.*

60mg Carton - 60mgcarton

60mg Carton - 60mgcarton

This appears to be a description of a medication called Panidonate sodium USP that comes in a vial containing 60mg of the medication. The medication is a lyophilized powder that requires dilution and intravenous infusion, with further consultation on dosage and administration required for each corresponding indication. The medication is manufactured by Areva Pharmaceuticals and the package includes instructions for preparation of the solution. The text includes details of the package, such as the NDC number. There is not enough information to identify the exact indications of the medication or its specific uses.*

90mg Vial - 90 mg label small

90mg Vial - 90 mg label small

This is a sterile, lyophilized vial of Pamidronate disodium USP 90 mg, manufactured by Cipa Ltd. and made in India. The reconstituted solution has a pH of 60-70 and should not be mixed with calcium-containing infusion solutions. Dilution and administration varies for each indication. It should be stored at 20° - 25°C (68° - 77°F). Further dilution may be necessary. Code No: GOIDRUGS/704.*

90mg Carton - 90mgcarton

90mg Carton - 90mgcarton

Description not available.*

Figure 1 - figure1

Figure 1 - figure1

This text describes a graph that shows the relationship between Pamidronate renal clearance and creatinine clearance in patients with normal and impaired renal function. The graph includes a mean prediction line and 95% confidence intervals.*

Structural Formula - structuralFormula

Structural Formula - structuralFormula

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.